Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of "Real-world" Evidence.
JAMA Dermatol. 2019 Jan 1;155(1):29-38. doi: 10.1001/jamadermatol.2018.3447.
JAMA Dermatol. 2019.
PMID: 30427977
Free PMC article.
Review.